femasys(FEMY) - 2025 Q2 - Quarterly Results

Femasys Announces Second Quarter Financial Results for 2025 -- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio -- ATLANTA, August 8, 2025 -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the second quarter of 2025. Corporate Highlights from 2Q 2025 to date "Our second quarter marked several significan ...